HomeDMYD-B • STO
add
Diamyd Medical AB
Nakaraang pagsara
kr 10.78
Sakop ng araw
kr 10.70 - kr 11.12
Sakop ng taon
kr 7.50 - kr 19.50
Market cap
1.49B SEK
Average na Volume
362.46K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | May 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 47.17M | 17.45% |
Net na kita | -43.88M | -9.50% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | -46.46M | -17.32% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | May 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 319.26M | 96.61% |
Kabuuang asset | 400.07M | 61.19% |
Kabuuang sagutin | 75.40M | 42.93% |
Kabuuang equity | 324.67M | — |
Natitirang share | 137.50M | — |
Presyo para makapag-book | 4.57 | — |
Return on assets | -41.41% | — |
Return on capital | -55.16% | — |
Cash Flow
Net change in cash
| (SEK) | May 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -43.88M | -9.50% |
Cash mula sa mga operasyon | -43.50M | -18.29% |
Cash mula sa pag-invest | -4.25M | 89.37% |
Cash mula sa financing | 258.96M | 321.52% |
Net change in cash | 215.51M | 1,626.72% |
Malayang cash flow | -31.45M | -36.16% |
Tungkol
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Itinatag
1984
Website
Mga Empleyado
30
